Oct132026

MHRA authorises Onswik (insulin efsitora alfa) for adults with type 2 diabetes

Public Health

The new treatment option is administered once weekly, potentially reducing the number of injections from up to 365 a year to 52 for some adults with type 2 diabetes.

Leave a Reply

Your email address will not be published.